$1.5 Billion is the total value of Camber Capital Management LP's 43 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 48.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF SPYput | $205,540,000 | – | 1,000,000 | +100.0% | 13.67% | – |
| TEVA | TEVA PHARMACEUTICALS INDS LTDadr | $100,643,000 | +7.0% | 1,750,000 | 0.0% | 6.69% | -24.3% | |
| MASI | Buy | MASIMO CORP | $75,069,000 | +30.7% | 2,850,000 | +5.6% | 4.99% | -7.6% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $74,795,000 | +35.6% | 1,750,000 | +45.8% | 4.97% | -4.1% |
| GHDX | Buy | GENOMIC HEALTH INC | $68,736,000 | +21.4% | 2,150,000 | +7.5% | 4.57% | -14.1% |
| CNMD | CONMED CORP | $62,270,000 | +22.0% | 1,385,000 | 0.0% | 4.14% | -13.7% | |
| ESRX | EXPRESS SCRIPTS HLDG CO | $59,269,000 | +19.9% | 700,000 | 0.0% | 3.94% | -15.2% | |
| LH | New | LABORATORY CORP AMER HLDGS | $53,950,000 | – | 500,000 | +100.0% | 3.59% | – |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $51,525,000 | +59.0% | 7,500,000 | +25.0% | 3.43% | +12.5% |
| 5100PS | Sell | VOLCANO CORPORATION | $45,594,000 | -15.1% | 2,550,000 | -49.5% | 3.03% | -39.9% |
| GSK | GLAXOSMITHKLINE PLCcall | $42,740,000 | -7.0% | 1,000,000 | 0.0% | 2.84% | -34.2% | |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $42,620,000 | +78.1% | 1,000,000 | +33.3% | 2.83% | +26.0% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $42,450,000 | -11.8% | 3,000,000 | -14.3% | 2.82% | -37.6% |
| UAM | Buy | UNIVERSAL AMERN CORP NEW | $42,399,000 | +26.2% | 4,568,898 | +9.3% | 2.82% | -10.7% |
| MYL | Sell | MYLAN INC | $42,278,000 | -33.6% | 750,000 | -46.4% | 2.81% | -53.0% |
| BRKR | Buy | BRUKER CORP | $39,240,000 | +111.9% | 2,000,000 | +100.0% | 2.61% | +49.9% |
| OFIX | Buy | ORTHOFIX INTL N V | $37,575,000 | +0.3% | 1,250,000 | +3.3% | 2.50% | -29.1% |
| MDCO | New | MEDICINES CO | $36,524,000 | – | 1,320,000 | +100.0% | 2.43% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $33,125,000 | – | 2,500,000 | +100.0% | 2.20% | – |
| SQNM | Buy | SEQUENOM INC | $32,375,000 | +36.3% | 8,750,000 | +9.4% | 2.15% | -3.6% |
| PFNX | New | PFIZER INCcall | $31,150,000 | – | 1,000,000 | +100.0% | 2.07% | – |
| TEVA | TEVA PHARMACEUTICALS INDS LTDcall | $28,755,000 | +7.0% | 500,000 | 0.0% | 1.91% | -24.3% | |
| WW | Buy | WEIGHT WATCHERS INTL INC NEW | $28,485,000 | +3.8% | 1,146,741 | +14.7% | 1.89% | -26.6% |
| KND | New | KINDRED HEALTHCARE INC | $27,270,000 | – | 1,500,000 | +100.0% | 1.81% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $27,179,000 | +290.5% | 525,000 | +232.0% | 1.81% | +176.3% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $23,792,000 | +192.1% | 1,748,100 | +92.5% | 1.58% | +106.5% |
| ALR | New | ALERE INC | $19,000,000 | – | 500,000 | +100.0% | 1.26% | – |
| CCRN | Buy | CROSS CTRY HEALTHCASE INC | $17,754,000 | +91.1% | 1,422,565 | +42.3% | 1.18% | +35.2% |
| TRVN | New | TREVENA INC | $17,163,000 | – | 2,870,000 | +100.0% | 1.14% | – |
| BIOL | Buy | BIOLASE INC | $14,590,000 | +115.8% | 5,547,694 | +104.3% | 0.97% | +52.8% |
| DGX | Sell | QUEST DIAGNOSTICS INC | $13,253,000 | -56.3% | 197,622 | -60.5% | 0.88% | -69.1% |
| NVAX | Sell | NOVAVAX INC | $11,860,000 | -40.1% | 2,000,000 | -57.9% | 0.79% | -57.6% |
| AMRN | AMARIN CORP PLCspons adr new | $11,756,000 | -10.1% | 12,000,000 | 0.0% | 0.78% | -36.4% | |
| AFFX | New | AFFYMETRIX INC | $9,870,000 | – | 1,000,000 | +100.0% | 0.66% | – |
| ANGO | ANGIODYNAMICS | $6,932,000 | +38.6% | 364,630 | 0.0% | 0.46% | -1.9% | |
| New | PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $6,904,000 | – | 9,000,000 | +100.0% | 0.46% | – | |
| CRDC | CARDICA INC | $5,862,000 | -34.6% | 8,374,846 | 0.0% | 0.39% | -53.7% | |
| TRGT | TARGACEPT INC | $4,103,000 | +4.0% | 1,560,000 | 0.0% | 0.27% | -26.4% | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $3,680,000 | -24.0% | 2,000,000 | 0.0% | 0.24% | -46.2% | |
| EGRX | New | EAGLE PHARMACEUTICAL INC | $3,106,000 | – | 200,400 | +100.0% | 0.21% | – |
| INO | INOVIO PHARMACEUTICALS INC | $2,295,000 | -6.8% | 250,000 | 0.0% | 0.15% | -33.8% | |
| BRLI | Sell | BIO-REFERENCE LABS INC | $369,000 | -97.6% | 11,485 | -97.9% | 0.02% | -98.3% |
| BIOL | New | BIOLASE INCcall | $139,000 | – | 1,841,173 | +100.0% | 0.01% | – |
| GERN | Exit | GERON CORP | $0 | – | -3,440,045 | -100.0% | -0.65% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -573,000 | -100.0% | -1.29% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -235,174 | -100.0% | -1.33% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -277,583 | -100.0% | -1.67% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -3,250,000 | -100.0% | -3.05% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -4.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2015-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.